|
|
|
|
LEADER |
03452nmm a2200625 u 4500 |
001 |
EB002082681 |
003 |
EBX01000000000000001222771 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
220928 ||| eng |
020 |
|
|
|a 9798400205996
|
100 |
1 |
|
|a Agarwal, Ruchir
|
245 |
0 |
0 |
|a A Global Strategy to Manage the Long-Term Risks of COVID-19
|c Ruchir Agarwal, Gita Gopinath, Jeremy Farrar, Richard Hatchett, Peter Sands
|
260 |
|
|
|a Washington, D.C.
|b International Monetary Fund
|c 2022
|
300 |
|
|
|a 26 pages
|
653 |
|
|
|a Economic Growth and Aggregate Productivity: General
|
653 |
|
|
|a Communicable diseases
|
653 |
|
|
|a Publicly Provided Goods: General
|
653 |
|
|
|a Economics
|
653 |
|
|
|a Economic & financial crises & disasters
|
653 |
|
|
|a Demographic Economics: General
|
653 |
|
|
|a Population and demographics
|
653 |
|
|
|a Covid-19
|
653 |
|
|
|a Macroeconomics
|
653 |
|
|
|a Infectious & contagious diseases
|
653 |
|
|
|a Financial crises
|
653 |
|
|
|a Population
|
653 |
|
|
|a Economics of specific sectors
|
653 |
|
|
|a Diseases: Contagious
|
653 |
|
|
|a Health care
|
653 |
|
|
|a Economic sectors
|
653 |
|
|
|a Industry Studies: Manufacturing: General
|
653 |
|
|
|a Health economics
|
653 |
|
|
|a Health Policy
|
653 |
|
|
|a Informal sector
|
653 |
|
|
|a Health systems & services
|
653 |
|
|
|a Health: General
|
653 |
|
|
|a Currency crises
|
653 |
|
|
|a Health Behavior
|
653 |
|
|
|a Analysis of Health Care Markets
|
653 |
|
|
|a Demography
|
653 |
|
|
|a Medical care
|
653 |
|
|
|a Population & demography
|
653 |
|
|
|a Health
|
653 |
|
|
|a Economics: General
|
700 |
1 |
|
|a Farrar, Jeremy
|
700 |
1 |
|
|a Gopinath, Gita
|
700 |
1 |
|
|a Hatchett, Richard
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b IMF
|a International Monetary Fund
|
490 |
0 |
|
|a IMF Working Papers
|
028 |
5 |
0 |
|a 10.5089/9798400205996.001
|
856 |
4 |
0 |
|u https://elibrary.imf.org/view/journals/001/2022/068/001.2022.issue-068-en.xml?cid=516079-com-dsp-marc
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 330
|
520 |
|
|
|a The pandemic is not over, and the health and economic losses continue to grow. It is now evident that COVID-19 will be with us for the long term, and there are very different scenarios for how it could evolve, from a mild endemic scenario to a dangerous variant scenario. This realization calls for a new strategy that manages both the uncertainty and the long-term risks of COVID-19. There are four key policy implications of such as strategy. First, we need to achieve equitable access beyond vaccines to encompass a comprehensive toolkit. Second, we must monitor the evolving virus and dynamically upgrade the toolkit. Third, we must transition from the acute response to a sustainable strategy toward COVID-19, balanced and integrated with other health and social priorities. Fourth, we need a unified risk-mitigation approach to future infectious disease threats beyond COVID-19. Infectious diseases with pandemic potential are a threat to global economic and health security. The international community should recognize that its pandemic financing addresses a systemic risk to the global economy, not just the development need of a particular country. Accordingly, it should allocate additional funding to fight pandemics and strengthen health systems both domestically and overseas. This will require about $15 billion in grants this year and $10 billion annually after that
|